Donate to Science & Enterprise

S&E on Mastodon

S&E on LinkedIn

Please share Science & Enterprise

Nasal Spray Vaccine Shown to Stop Gonorrhea Infections

Neisseria gonorrhoeae bacteria

A vaccine against gonorrhea given as a nasal spray is shown to generate protective immune responses in lab mice of both sexes, and in females similar to an intravaginal vaccine. . . . → Read More: Nasal Spray Vaccine Shown to Stop Gonorrhea Infections

Environmental Biomarker Start-Up Gains $16M in Early Funds

Human body hair sample

A new company developing diagnostics for neurological and other disorders based on environmental exposures is raising $16 million in venture funds. . . . → Read More: Environmental Biomarker Start-Up Gains $16M in Early Funds

Company Started for Gene Editing Rare Inherited Diseases

Mitochondria illustration

A new enterprise is formed to develop gene-editing therapies for mitochondrial disorders, rare inherited mutations in the energy centers of cells. . . . → Read More: Company Started for Gene Editing Rare Inherited Diseases

Peptide Discovery Company to Gain $3.3B in Licensing Deals

Test tubes in a lab

A discoverer of therapeutic peptides signed licensing deals in the past few days with two drug makers that could bring the company as much as $3.3 billion. . . . → Read More: Peptide Discovery Company to Gain $3.3B in Licensing Deals

Venture Investor to Back Semiconductor Start-Ups

Circuit board illustration

A technology investment company is partnering with a Silicon Valley incubator program to support start-up businesses developing new types of semiconductors. . . . → Read More: Venture Investor to Back Semiconductor Start-Ups

Biotech, Regeneron in $2B Cancer Antibody Deal

Cancer magnified

A developer of cancer treatments triggered by tumor chemistry is partnering with biologic drug maker Regeneron on dual-action cancer immunotherapies. . . . → Read More: Biotech, Regeneron in $2B Cancer Antibody Deal

Company to Boost Orphan Drugs in Europe

Europe at night from space

A start-up enterprise seeks to make drugs for treating rare diseases more readily available to physicians and patients in Europe. . . . → Read More: Company to Boost Orphan Drugs in Europe

Covid-19 Vaccine Patch Clinical Trial Begins

Vaccine patch

Developers of a patch with tiny needles instead of a syringe to deliver vaccines say a clinical trial testing a Covid-19 patch is now underway in Australia. . . . → Read More: Covid-19 Vaccine Patch Clinical Trial Begins

Trial in Progress of Antibody Blocking Covid-19 in Immunocompromised

Global Covid-19

A clinical trial is underway testing a synthetic antibody designed to prevent SARS-CoV-2 viral infections in people with compromised immune systems. . . . → Read More: Trial in Progress of Antibody Blocking Covid-19 in Immunocompromised

Drug Licensed for Precision Autism Spectrum Therapies

Brain activity graphic

A company making precision therapies for neurological disorders is acquiring rights to a compound first designed as a treatment for cancer, inflammation, and oxidative stress. . . . → Read More: Drug Licensed for Precision Autism Spectrum Therapies